Malegra 200 mg is a medication that is primarily used in the treatment of erectile dysfunction (ED). It consists of 200 mg of sildenafil citrate, which belongs to the PDE-5 inhibitor class of drugs. It works by facilitating the relaxation of smooth muscle tissues and improving the blood flow in the region. 200 mg of sildenafil citrate is a higher dose than normally prescribed. Hence, Malegra 200 mg must be consumed strictly under the instruction of a healthcare professional.
1.Erectile Dysfunction (ED)
Erectile dysfunction refers to the inability of an individual to achieve or sustain an erection for a sufficient amount of time. ED is the primary, off-label indication treated by Malegra 200 mg. It improves blood flow in patients who are unresponsive to a 50- or 100-mg dose. Malegra 200 mg is especially effective in long-standing ED, where higher doses of sildenafil citrate may be required.
2.Erectile Dysfunction (ED) Associated With Other Medical Conditions
In some cases, ED results as a secondary symptom due to underlying conditions such as diabetes mellitus (diabetic neuropathy or vascular damage), hypertension, atherosclerosis, or post-prostate surgery. In such cases, the vascular systems might be impaired. Hence, the treatment of ED might require a higher dosage. Malegra 200 mg provides a sufficient sildenafil concentration for ED due to underlying conditions.
3.Pulmonary Arterial Hypertension (PAH)
PAH is a chronic, progressive disorder that consists of excessive pressure in the pulmonary artery. Generally, a 200 mg dose of sildenafil citrate is not prescribed for PAH. However, in some patients, this dosage is administered only under strict medical supervision. For severe PAH, Malegra 200 mg can be used to dilate the pulmonary artery and restore the optimum blood flow in the region.
4.Off-label Indications
Erectile dysfunction (primary indication):
Severe or refractory erectile dysfunction (non-responsive to 100 mg):
Erectile dysfunction associated with diabetes or vascular disease:
Erectile dysfunction post-prostate surgery or neurological causes:
Antidepressant-induced erectile dysfunction (off-label):
Makegra 200 mg consists of 200 mg of the drug sildenafil citrate. Sildenafil citrate is a selective PDE-5 inhibitor that helps improve local blood flow in the body. It targets the NO-cGMP pathway that is involved in regulating the local blood circulation.
The NO-cGMP pathway is activated only in response to external triggers (sexual stimulation, endothelial signalling, nerve excitation). In response to external stimulation, the parasympathetic nerve endings or endothelial cells release nitric oxide (NO), which rapidly diffuses into the surrounding tissues. This NO activates the guanylate cyclase enzyme, which is responsible for converting the inactive guanosine triphosphate (GTP) to highly active cyclic guanosine monophosphate (cGMP). The cGMP is the key molecule in regulating further physiological processes in the region.
The cGMP molecules facilitate a reduction in the intracellular calcium and the movement of potassium into the cells, which leads to smooth muscle relaxation. As a result, the blood vessels in the tissues dilate (vasodilation). This results in increased blood flow, which is required in several organ systems such as the penis, pulmonary artery, and the extremities.
An enzyme called phosphodiesterase type-5 (PDE-5) is released as a feedback reaction to excess cGMP. It degrades the cGMP molecules, thus fading their vasodilatory and smooth muscle relaxing effects. This reaction is important to bring the body back to its resting state. Without the PDE-5 effect, the smooth muscles might remain relaxed for longer than required, and the vasodilation may persist indefinitely.
However, in some individuals, the PDE-5 effect is observed prematurely or in excess. As a result, the required cGMP effect is not obtained. This leads to local abnormalities like excess blood vessel constriction, vascular toning, etc. These abnormalities manifest in the form of various disorders, such as erectile dysfunction, pulmonary arterial hypertension, etc.
Malegra 200 mg is prescribed for such disorders as it selectively targets the overexpressed/premature PDE-5 enzyme. As a result, the cGMP molecules are in sufficient quantity to facilitate the required physiological changes. Using this mechanism, Malegra 200 mg facilitates the relaxation of smooth muscles and improves blood flow in the region, which alleviates the above-listed conditions.
1.Common (Mild to Moderate)
2.Cardiovascular Effects
3.Visual & Ocular Effects (Due to PDE-6 Inhibition)
4.Auditory Effects
5.Gastrointestinal Effects
6.Genitourinary Effects
7.Neurological Effects
8.Respiratory Effects
9.Dermatological / Hypersensitivity Reactions
10.Serious but Rare Complications
1.How long does Malegra 200 mg stay in the body?
The effects of Malegra 200 mg typically last for up to 4-6 hours, and the medication stays in the body for up to 24 hours.
2.How long does it take for Malegra 200 mg to start acting?
Generally, it takes 30-60 minutes for Malegra 200 mg to start acting. However, this timing depends on several factors such as age, metabolism, meal intake, etc.
3.Can Malegra 200 mg be taken daily?
Malegra 200 mg contains a high dose of sildenafil citrate, higher than normally prescribed. This medication must not be consumed daily, unless explicitly stated by a medical care professional.
4.Does Malegra 200 mg increase sexual desire?
Malegra 200 mg acts by enhancing the normal reactions involved in the penile functions. However, it does not induce or increase sexual desire in any way.
5.Can Malegra 200 mg affect fertility?
There is no research confirming the negative effects of sildenafil citrate, present in Malegra 200 mg, on the fertility of the individual consuming this medication.
Be the first to share your experience with this product!